Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 255-288-2 | CAS number: 41272-40-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Not GLP study, not good described. Read across from a similar substance which has the same main component and with a different counter ion that doesn't influence the characteristics related to the specific end-point
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- publication
- Title:
- Toxicological studies on malachite green: A triphenylmethane dye
- Author:
- Clemmensen S., Jensen C., Jensen N., Meyer O., Olsen P., Wurtzen G.
- Year:
- 1 984
- Bibliographic source:
- Arch Toxico l1984) 56: 43-45
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 475 (Mammalian Bone Marrow Chromosome Aberration Test)
- Deviations:
- not specified
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Malachite Green Oxalate
- IUPAC Name:
- Malachite Green Oxalate
- Details on test material:
- - Name of test material: Malachite Green Oxalate
- Source: Dansk Orredforder A/S, Brande, Danmark
- Structure: (C23H25N)2 (COO)2 X 2 (COOH)2
- Analytical purity: > 90% detected by TLC
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- - Source: G1. Bomholtgard, Ry, Denmark
Administration / exposure
- Route of administration:
- oral: gavage
- Duration of treatment / exposure:
- Single exposure
- Frequency of treatment:
- Single exposure
Doses / concentrations
- Remarks:
- Doses / Concentrations:
37.5 mg/kg
Basis:
nominal in diet
- No. of animals per sex per dose:
- 5 animals
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- 50 mg cyclophosphamide/kg bw
Examinations
- Tissues and cell types examined:
- Animals were killed at 24, 42 and 66 hours after dosing. Bone marrow smears were prepared from each animals and stained with May-Grunwald/Giemsa. One thousand polychromatic erythrocytes were counted.
Results and discussion
Any other information on results incl. tables
After a single exposure of 37.5 mg/kg bw, 0.07, 0.13 and 0.11% micronuclei were counted at sampling times 24, 42, 66 hours while the percent of micronuclei in the positive control was 1.55, 2.03 and 0.70 and in negative control 0.16%
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
No clastogenic effects were demonstrated in this micronucleus test - Executive summary:
The micronuclei test on mice was carried out to determine the potential chromosome damaging effect. Groups of five animals were given the maximum tolerated dose (37.5 mg/kg) by garage.
No significant increase in the number of micronuclei was found in any of the treated groups. After a single exposure of 37.5 mg/kg body weight, 0.07, 0.13, and 0.11% micronuciei were counted at sampling times 24, 42, or 66 h while the per cent of micronuclei in the positive control was 1.55, 2.03, and 0.70 and in the negative control (distilled water) 0.16%.
No clastogenic effects were demonstrated in this micronucleus test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.